FDA indicators publication whilst GH is permitted; off-label use requires strong proof, cautious monitoring

https://www.inkitt.com/eblicitzff

FDA signs publication whilst GH is approved; off-label use calls for strong facts, cautious monitoring, and clear consent discussions.